Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 3
1995 1
1996 2
1997 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
[No authors listed] [No authors listed] Arch Ophthalmol. 1994 Apr;112(4):500-9. Arch Ophthalmol. 1994. PMID: 7512336 Clinical Trial.
Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group.
[No authors listed] [No authors listed] Arch Ophthalmol. 1997 Jun;115(6):741-7. doi: 10.1001/archopht.1997.01100150743009. Arch Ophthalmol. 1997. PMID: 9194725 Clinical Trial.
Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
[No authors listed] [No authors listed] Arch Ophthalmol. 1993 Sep;111(9):1189-99. doi: 10.1001/archopht.1993.01090090041018. Arch Ophthalmol. 1993. PMID: 7689826 Clinical Trial.
Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group.
[No authors listed] [No authors listed] Arch Ophthalmol. 1993 Sep;111(9):1200-9. doi: 10.1001/archopht.1993.01090090052019. Arch Ophthalmol. 1993. PMID: 7689827 Clinical Trial.
Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.
[No authors listed] [No authors listed] Arch Ophthalmol. 1996 Apr;114(4):400-12. Arch Ophthalmol. 1996. PMID: 8602776 Clinical Trial.
Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Macular Photocoagulation Study Group.
[No authors listed] [No authors listed] Arch Ophthalmol. 1994 Apr;112(4):480-8. doi: 10.1001/archopht.1994.01090160056023. Arch Ophthalmol. 1994. PMID: 7512334 Clinical Trial.
The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
[No authors listed] [No authors listed] Arch Ophthalmol. 1995 Feb;113(2):190-4. doi: 10.1001/archopht.1995.01100020074032. Arch Ophthalmol. 1995. PMID: 7532395 Clinical Trial.
Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Macular Photocoagulation Study (MPS) Group.
[No authors listed] [No authors listed] Arch Ophthalmol. 1994 Sep;112(9):1176-84. doi: 10.1001/archopht.1994.01090210060017. Arch Ophthalmol. 1994. PMID: 7522004 Clinical Trial.
Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
[No authors listed] [No authors listed] Arch Ophthalmol. 1996 Jun;114(6):677-88. doi: 10.1001/archopht.1996.01100130669006. Arch Ophthalmol. 1996. PMID: 8639078 Clinical Trial.
Feedback